A specialist in home infusion IV therapies has signed a lease at 80 Hayden Ave. in Lexington for its new eastern headquarters.
KabaFusion is relocating from 318 Bear Hill Road in Waltham to the 43,208-square-foot Hayden Ave. office building.
Newmark Knight Frank represented owners Marwick Assoc. of Lexington in the transaction, while Cushman & Wakefield represented KabaFusion.
KabaFusion joins a cluster of more than 2 million square feet leased to life science companies in the Lexington and Waltham submarket, including Takeda Pharmaceuticals, Concert Pharmaceuticals, ElevateBio and Dicerna Pharmaceuticals, Newmark Executive Managing Director Mark Roth said in a statement.